GUBRA
Gubra is a peptide-focused biotech company that provides high-end preclinical contract research and peptide-based drug discovery services. It specializes in metabolic and fibrotic diseases, offering advanced models, imaging, and analytics to accelerate early-stage development. The company operates from Denmark (Headquarters in Hørsholm) with a presence in the United States (Boston) and collaborates with global partners to advance peptide therapeutics from discovery to development.
No recent deals for this company.